NORLIP

Country: Израел

Језик: Енглески

Извор: Ministry of Health

Купи Сада

Активни састојак:

BEZAFIBRATE

Доступно од:

UNIPHARM LTD, ISRAEL

Фармацеутски облик:

TABLETS

Састав:

BEZAFIBRATE 200 MG

Пут администрације:

PER OS

Тип рецептора:

Required

Произведен од:

UNIPHARM LTD, ISRAEL

Терапеутске индикације:

Reduction of elevated blood levels of cholesterol and triglycerides.

Датум одобрења:

2021-01-31

Информативни летак

                                PATIENT PACKAGE INSERT IN
ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS )PREPARATIONS( – 1986
The medicine is dispensed with
a doctor’s prescription only
NORLIP
TABLETS
COMPOSITION:
Each NORLIP tablet contains:
Bezafibrate 200 mg
For a list of inactive and allergenic ingredients in
the preparation, please see section 6: “Further
information”. See also section 2: “Important
information about some of the ingredients of
the medicine”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY
BEFORE USING THE MEDICINE. This leaflet
contains concise information about the medicine.
If you have further questions, refer to the doctor
or pharmacist.
The medicine has been prescribed to treat your
ailment. Do not pass it on to others. It may harm
them even if it seems to you that their medical
condition is similar.
This preparation is not intended for use in
children.
1. WHAT IS THE MEDICINE INTENDED FOR?
THERAPEUTIC ACTIVITY: to lower the level of
cholesterol and triglycerides )lipids( in the blood,
in cases where dietary treatment alone is not
effective.
THERAPEUTIC GROUP: Fibrates.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
• you are sensitive )allergic( to the active
ingredient bezafibrate or to any of the
additional ingredients contained in the
medicine )see section 6(.
• you are sensitive )allergic( to other fibrates or
you have developed sensitivity to sunlight or
artificial light )e.g., tanning beds( during the
treatment with fibrates.
• you are taking medicines from the statin family
)e.g., atorvastatin( and are suffering from the
following conditions, which may increase
the risk of developing a muscle disease
118818010
01B21
)weakness, muscle tissue breakdown or
muscle pain(:
- kidney dysfunction.
- an underactive thyroid )hypothyroidism(.
- severe infection.
- trauma.
- surgery.
- changes in hormone or chemical levels in
your body )seen in blood tests(.
- high alcohol consumption.
• you are being treated with dialysis.
• you have a liver disease.
• you have a gallbladder disease.
• you a
                                
                                Прочитајте комплетан документ
                                
                            

Документи на другим језицима

Информативни летак Информативни летак Арапски 23-11-2021
Информативни летак Информативни летак Хебрејски 23-11-2021

Обавештења о претрази у вези са овим производом

Погледајте историју докумената